YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Novartis to buy cancer-drug maker for $2B

Posted online

Novartis AG announced it would purchase Endocyte Inc. for $2.1 billion.

The acquisition would give the Swiss pharmaceutical company access to Endocyte's so-called radiopharmaceuticals, which carry radioactive substances to kill tumor cells.

Endocyte is currently developing a new treatment for prostate cancer.

Read more from The Wall Street Journal.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Annual downtown holiday events combine for Nov. 21 celebration

Organizers hope to bolster client traffic to center city businesses.

Most Read
SBJ.net Poll
How often do you use artificial intelligence for your business?

*

View results

Update cookies preferences